Tablets

Jul 29, 2015 at 12:33 | Source: PTI
Armed with new innovative features like Cortana, an Xbox app and Microsoft Edge, the long-awaited Windows 10 would be available to computers and tablets in 190 nations.
Jul 28, 2015 at 14:11 | Source: PTI
Microsoft's new Windows 10 operating system debuts tomorrow, as the longtime leader in PC software struggles to carve out a new role in a world where people increasingly rely on smartphones, tablets and information stored online.
Jul 19, 2015 at 19:03 | Source: PTI
On the back of three successful acquisitions in health and pharma space in past six months, pure-play cloud player 8K Miles Software is looking at more buyouts in the same area as it seems a huge opportunity in the US following the legal mandate to Obamacare.
Jul 14, 2015 at 11:46 | Source: Moneycontrol.com
Dr Reddy's Laboratories has launched Memantine hydrochloride tablets, USP, 5 mg and 10 mg, in the US market on July 12.
Jul 14, 2015 at 10:00 | Source: Moneycontrol.com
Dr Reddy's Labs rallied 1.5 percent as the company launched its Memantine hydrochloride tablets (a generic version of Namenda) in the US while Sun Pharma slipped half a percent as sources told CNBC-TV18 that USFDA has audited company's API facility in Ahmednagar, Maharashtra.
Jul 13, 2015 at 22:27 | Source: PTI
Microsoft will launch Windows 10, a successor to the current Windows 8.1 operating system, across 190 countries on July 29 as a free upgrade or with new PCs and tablets.
Jul 13, 2015 at 20:44 | Source: PTI
Drug firm Dr Reddy's Laboratories has launched in the US market the generic Memantine hydrochloride tablets used for treatment of dementia of the Alzheimer's type.
Jul 13, 2015 at 15:47 | Source: Moneycontrol.com
Dr Reddy's Laboratories has announced Memantine hydrochloride tablets USP, 5 mg and 10 mg, a therapeutic equivalent version of NAMENDA tablets in the US markets on July 12, 2015 approved by USFDA.
Jul 12, 2015 at 16:11 | Source: PTI
The panel may also consider TRAI recommendation on allowing virtual network operators (VNO) to operate in the country. They are expected operate as retailer of different telecom operators under one roof and provide one bill to customers for a host of services.
Jul 10, 2015 at 12:58 | Source: PTI
"The approved ANDA (Abbreviated New Drug Application) is bioequivalent and therapeutically equivalent to the reference listed drug product (RLD) Tambocor Tablets, 50 mg, 100 mg, 150 mg," the company said.
Messages on Tablets »

madrasan

Silver Member

1 Followers

Shasun Pharma  

a license to sell a generic version of Renvela (sevelamer carbonate) 800-mg tablets beginning March 16, 2014. Impax can also sell oral suspension versions of Renvela and Renagel (sevelamer hydrochloride) beginning September 16, 2014.

12.48 PM Jul 8th 2014

BSE/NSE Announcer

Platinum Member

8727 Followers

Glenmark  

Glenmark Pharmaceuticals Limited has informed the Exchange regarding the press release dated July 08, 2014 titled,"Glenmark Generics receives final ANDA approval for Telmisartan Tablets."

12.41 PM Jul 8th 2014

BSE/NSE Announcer

Platinum Member

8727 Followers

Glenmark  

Glenmark Generics Inc., USA a subsidiary of Glenmark Generics has been granted final abbreviated new drug approval (ANDA) from the United States Food and Drug Administration (US FDA) for Telmisartan Tablets. Glenmark will commence distribution of the product immediately.

12.04 PM Jul 8th 2014

BSE/NSE Announcer

Platinum Member

8727 Followers

Glenmark  

Glenmark Pharmaceuticals Ltd has informed BSE regarding a Press Release dated July 08, 2014 titled "Glenmark Generics receives final ANDA approval for Telmisartan Tablets" Glenmark Generics Inc., USA a subsidiary of Glenmark Generics has been granted final abbreviated new drug approval (ANDA) from

12.04 PM Jul 8th 2014

phs25

Gold Member

9 Followers

Glenmark  

Glenmark Generics receives final ANDA approval for Telmisartan Tablets | 07/08/14 12:01 Glenmark Pharmaceuticals Ltd has informed BSE regarding a Press Release dated July 08, 2014 titled "Glenmark Generics receives final ANDA approval for Telmisartan Tablets

12.03 PM Jul 8th 2014

aindia

Silver Member

197 Followers

Ybrant Digital  

% growth for the first time since 2004, when ad spending increased 6.7%. Mobile will lead this year’s rise in total media ad spending in the US, and advertisers will spend 83.0% more on tablets and smartphones than they did in 2013—an increase of $8.04 billion. By the end of this year, mobile

7.34 PM Jul 2nd 2014

Web Messenger

Platinum Member

300228 Followers

Mobile Tele  

Source:VC Circle - Samsung-Galaxy-Tab-S After unveiling the same last month, Samsung has now launched its Galaxy Tab S range of tablets in the Indian market. The tablets are available in 8.4 and 10.5 inch display screen sizes and according to the company, these are the ...

3.16 PM Jul 2nd 2014

Web Messenger

Platinum Member

300228 Followers

Mobile Tele  

Source:Money Rediff News Report - Sony's flagship tablet - the Xperia Z2 Tablet - after going on sale in some parts of the world, has now become available in India at an online retailer at a price of Rs. 49,990 for its 4G LTE variant. The tablet is also listed on the official website

3.16 PM Jul 2nd 2014

Web Messenger

Platinum Member

300228 Followers

Mobile Tele  

Source:Money Rediff News Report - Korean electronics giant Samsung today launched its new tablet 'Tab S' for Rs 37,800 onwards, to further strengthen its position in the Indian market. The device will be available in two screen sizes - 8.4 inch and 10.5 inch - priced at Rs 37,800 and

3.16 PM Jul 2nd 2014

Web Messenger

Platinum Member

300228 Followers

News Now  

Source:Economic Times - Hybrids and Detachables When Microsoft launched Windows 8 with a touch-optimized interface, a number of manufacturers launched hybrid and detachable devices that offered the benefit of a traditional laptop as well as a tablet. These hybrids are easy to carry around, have

3.12 PM Jul 2nd 2014

News across the web »
Explore Moneycontrol

Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.